As Algeria’s pharmaceutical sector accelerates its transformation, Advanced Med Pharma is emerging as a pivotal force and strategic partner for both local and foreign investors seeking to establish a foothold in the country’s booming medicines and medical devices industry.
Dr. Chamli Hassiba, founder and CEO of Advanced Med Pharma, told dzwatch that the company plays a leading role in regulatory affairs, covering medical device certification, drug registration of all categories, full preparation of technical and reimbursement dossiers, and product release procedures before the National Pharmaceutical Products Agency (ANPP).
Dr. Bouam Fatima Zohra, Technical Director and Consultant, outlined the company’s end-to-end support for producers — from factory design and cleanroom setup to raw material sourcing, equipment qualification, and quality control laboratory establishment.
Reflecting Algeria’s ambition to become a regional pharmaceutical hub, Advanced Med Pharma also adapts international manufacturers’ technical files to meet local regulatory requirements, ensuring safe and compliant market entry while boosting domestic production and reducing import costs.
